ANTX · CIK 0001880438 · operating
AN2 Therapeutics, Inc. (ANTX) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $29 million, AN2 Therapeutics, Inc. is a micro-cap company. The stock currently trades at $1.10, down 0.18% today, with a 52-week range of $1.00–$1.55.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.72 | $-1.72 | +37.2% | |
| 2023 | $-2.74 | $-2.74 | +1.8% | |
| 2022 | $-2.79 | $-2.79 | — |